Editor's Correspondence |

Efficacy and Relevance of Topical Diclofenac for Osteoarthritic Pain

Sita M. A. Bierma-Zeinstra, PhD; Janneke N. Belo, MD, MSc; Siep Thomas, MD, PhD
Arch Intern Med. 2005;165(5):588-589. doi:10.1001/archinte.165.5.588-b.
Text Size: A A A
Published online


Roth and Shainhouse1 reported in the ARCHIVES a well-designed randomized controlled trial on efficacy and safety of a topical diclofenac solution in the treatment of primary osteoarthritis of the knee. For clinical implementation we argue that additional information is needed.

In the sample size calculation, the authors state that they wanted to detect a clinically significant difference of 2 (SD of 4.5) in the change in Western Ontario McMaster Universities LK3.1 OA Index (WOMAC) pain dimension scores. To detect this difference, they needed a sample size of at least 80 in each treatment arm, but they decided to use a sample size of 200 patients (100 per treatment arm) to allow for a nonevaluable rate of 20%. In the trial, however, they included 326 patients, leading to 322 evaluable patients for the intent-to-treat analysis (163 in the topical diclofenac group and 159 in the vehicle-control group). Without any explanation the study size has almost been doubled compared with the original sample size calculation. Subsequently, the authors detected a statistically significant difference of 1.6 in change in the WOMAC pain score in favor of the topical diclofenac group, a smaller difference than originally stated as clinically significant.

Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

First Page Preview

View Large
First page PDF preview





Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment


Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Topics
PubMed Articles